Showing results (191-200 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|August 15, 2018
A pharmacogenetics approach to pain managementKaori Yoshida, Daisuke Nishizawa, Soichiro Ide, et al.Neuropsychopharmacology Reports|August 15, 2018
A randomized controlled study of the effect of ifenprodil on alcohol use in patients with alcohol dependenceNagisa Sugaya, Yasukazu Ogai, Yuzo Aikawa, et al.Neuropsychopharmacology Reports|September 8, 2020
Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphineXiayun Wan, Yuko Fujita, Lijia Chang, et al.Neuropsychopharmacology Reports|September 8, 2020
Noradrenaline enhances the excitatory effects of dopamine on medial prefrontal cortex pyramidal neurons in ratsFumiya Shinohara, Saya Arakaki, Taiju Amano, et al.Neuropsychopharmacology Reports|June 30, 2021
Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levelsMinami Tasaki, Norio Yasui-Furukori, Saaya Yokoyama, et al.Neuropsychopharmacology Reports|July 2, 2021
Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart reviewTaro Kishi, Kenji Sakuma, Makoto Okuya, et al.Neuropsychopharmacology Reports|March 17, 2020
Time estimation in a case of Tourette's syndrome: Effect of antipsychotic medicationsTakuma Inagawa, Natsuki Ueda, Kazuyuki Nakagome, et al.Neuropsychopharmacology Reports|September 20, 2020
Validity of self-reporting depression in the Tabari cohort study populationMehran Zarghami, Fatemeh Taghizadeh, Mahmood Moosazadeh, et al.Neuropsychopharmacology Reports|August 31, 2020
Neuropsychological characteristics of adults with attention-deficit/hyperactivity disorder without intellectual disabilityMasami Hida, Wakaho Hayashi, Yuka Okajima, et al.Pageof 66